Welcome to Lone Oak Medical Technologies
Discover accudxa2™ - Eight solid reasons for choosing the accudxa2
Model 7200 Bone Mineral Density Assessment System
accudxa2 uses the best technology
For BMD assessment, accudxa2 uses DXA technology, the gold
standard in bone densitometry.
accudxa2 is a highly affordable BMD assessment system. Medicare
($35-$50) and most private insurance companies ($75) currently
reimburse, giving potential for quick return on investment.
accudxa2's ease of use and short test time will help attract
Increased quality of care
accudxa2 enables physicians to comply with National Osteoporosis
Testing recommendations, and helps manage periodic osteoporosis
screening for at-risk patients.
Scatter to the operator is only 1/15,000th of the weekly
radiation exposure limit. Patient exposure is 0.0003 uSv
or 1/150,000th of a typical chest x-ray.
The accudxa2 analyzes the finger, a site with over 50 years
of clinical acceptance. accudxa2's low precision error (<1%)
allows for the detection of changes over time.
Ease of use
accudxa2's finger measurement procedure requires no messy creams or gels, and the patient does not need to remove any garments in order to take the test. The scan time is less than ten seconds, and the overall exam can be completed in two minutes. With its touchscreen front panel, accudxa2 is completely self contained and does not require an external computer.
The accudxa2 features a preset radiographic technique that cannot be changed by the operator. This allows anyone on the medical staff to operate the unit under the doctor's supervision. The unit's laser alignment positioning ensures accurate placement of the hand with every test. Plus, the Model 7200's increased computer memory provides added capabilities.
New accudxa2 Accessories Available
Lone Oak Medical Technologies now offers new accessories for your accudxa2. Visit our accessories page for information and pricing.
Lone Oak Medical Technologies, LLC
US-based Lone Oak Medical Technologies has a support team
dedicated to helping accudxa2 customers get the most from
their machines. We provide telephone and e-mail support.
Lone Oak offers a comprehensive warranty program for the
accudxa2 and with our on-line registration process you can
stay up-to-date on accudxa2 news and updates.
Lone Oak Medical Technologies is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved its accudxa2 Bone Mineral Density Assessment System for the U.S. market. Unlike Central DXA devices that measure the bone mineral density (BMD) of the hip and spine, the accudxa2 Peripheral DXA (pDXA) device accurately measures the bone density of the finger — a site with over 50 years of clinical acceptance. [Read More]
U.S. Food and Drug Administration Report on the Model 7200 accudxa2 Bone Mineral Density Assessment System.
Home / Product Overview / Company Background / Dealer Listing / accudxa2 ROI
News Archive / User Regisration / Support / Contact Information / Accessories / Resource Links
Website Maintenance by the Russell-Risko Agency.
© Copyright 2013, Lone Oak Medical Technologies, LLC. All Rights Reserved.